FDA Panel Votes 12 To four to Approve Puma's Breast melanoma Drug - Forbes

[unable to retrieve full-text content]ForbesFDA Panel Votes 12 To 4 to Approve Puma's Breast cancer DrugForbe sA panel of specialists convened through the food and Drug Administration says that a drug for breast melanoma developed by way of Puma Biotechnology may still be approved, however argued for more limits on which ladies should still get the medication. The drug, neratinib, became tested ...U.S. FDA panel backs Puma Biotech's breast cancer drug; stock soarsNasdaqUS FDA panel backs Puma Biotech's breast melanoma drugReutersupdate 1-U.S. FDA panel backs Puma Biotech's breast cancer drugMarkets Insiderall 62 information articles »